MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52

J Healthc Eng. 2022 Feb 16:2022:4033373. doi: 10.1155/2022/4033373. eCollection 2022.

Abstract

Background: Many researchers have confirmed that miRNAs are involved in the pathogenesis of gastric cancer (GC). This study focused on investigating the specific functions of miR-139-5p in GC.

Methods: MiR-139-5p and TPD52 expressions were observed by qRT-PCR or western blot in GC. The functional mechanism of miR-139-5p was explored by the luciferase reporter assay, transwell assay, and MTT assay.

Results: MiR-139-5p downregulation and TPD52 upregulation were detected in GC. Adverse clinical features and prognosis in GC patients were related to low miR-139-5p expression. MiR-139-5p overexpression restrained GC cell proliferation and metastasis. Furthermore, miR-139-5p directly targeted TPD52. TPD52 silencing blocked GC progression. And TPD52 upregulation weakened the antitumor effect of miR-139-5p in GC.

Conclusion: MiR-139-5p inhibits GC cell proliferation and metastasis through downregulating TPD52.

Publication types

  • Retracted Publication

MeSH terms

  • Cell Proliferation / genetics
  • Down-Regulation
  • Gene Expression Regulation, Neoplastic
  • Humans
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Neoplasm Proteins / metabolism
  • Stomach Neoplasms* / metabolism

Substances

  • MIRN139 microRNA, human
  • MicroRNAs
  • Neoplasm Proteins
  • TPD52 protein, human